In this issue of Blood, Bartlett et al share their experience with the use of ibrutinib in patients with relapsed or refractory follicular lymphoma (FL).
CITATION STYLE
Awan, F. T. (2018, January 11). Choosing ibrutinib wisely. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-11-813907
Mendeley helps you to discover research relevant for your work.